Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse-Reference-Cited by-同舟云学术

Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse

Published:2021-09-15 Issue:11 Volume:44 Page:1193-1208
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Bahri Priya,Pariente Antoine

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-021-01111-w.pdf

Reference44 articles.

1. Arlett P, Straus S, Rasi G. Pharmacovigilance 2030. Clin Pharmacol Ther. 2020;107:89–91.

2. Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J, et al. on behalf of the ISPE BRACE SIG. Benefit-risk assessment, communication and evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist. Pharmacoepidemiol Drug Saf. 2015;24:1233–40.

3. Rocca E, Anjum RL. Erice call for change: utilising patient experiences to enhance the quality and safety of healthcare. Drug Saf. 2020;43:513–5.

4. Brown P, Bahri P. ‘Engagement’ of patients and healthcare professionals in regulatory pharmacovigilance: establishing a conceptual and methodological framework. Europ J Clin Pharmacol. 2019;75:1181–92.

5. Rowe G, Frewer L. A typology of public engagement mechanisms. Sci Technol Hum Values. 2005;30:251–90.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System;Drug Safety;2024-07-10

2. Collaborative Approaches to Establishing and Implementing Pharmacovigilance Systems;Principles and Practice of Pharmacovigilance and Drug Safety;2024

3. Patient and Public Involvement in Pharmacovigilance;Principles and Practice of Pharmacovigilance and Drug Safety;2024

4. Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making;Drug Safety;2023-12-11

5. The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed;Drug Safety;2023-05-25